Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 15 of the 16 references it cites were found in a registry or an index; 7 of the 16 sources its claims cite were checked for support.

Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.

Open access

Abstract

Initial clinical trial results showed safe, feasible, and reversible focused-ultrasound BBB opening in the hippocampus and entorhinal cortex of early AD patients.

Overview

CoChat Summary

## TL;DR

This open-label phase II trial reports that MR-guided low-intensity focused ultrasound (FUS) can safely, reversibly, and repeatedly open the blood-brain barrier (BBB) in the hippocampus/entorhinal cortex of patients with early Alzheimer’s disease. In 6 participants and 17 treatment sessions, BBB opening was immediate, sizable, and transient, with no treatment-related adverse effects or neurological worsening reported.

## Key findings

  • Six participants (5 female, 1 male; ages 55–73) underwent a total of 17 FUS treatment sessions targeting the hippocampus/entorhinal cortex.
  • All 17 sessions produced immediate hippocampal parenchymal enhancement on contrast MRI, indicating BBB opening, with no off-target enhancement.
  • BBB opening resolved within 24 hours after treatment.
  • MRI-based volumetric analysis found BBB opening covered 95 ± 4% of the FUS-targeted volume, ranging from 318 mm³ to 873 mm³, corresponding to 14% to 71% of the overall hippocampal volume, with an average of 29%.
  • There were no treatment-related adverse effects or neurological changes up to 15 months post-FUS, and formal cognitive assessments at 30 days after the last treatment in the first five subjects showed no clinically meaningful changes.

## Methods

  • Design: Open-label, prospective phase II clinical trial sponsored by INSIGHTEC, with repeated MR-guided low-intensity FUS to the hippocampus and entorhinal cortex.
  • Sample/data: 6 patients with early AD enrolled at two sites (West Virginia University Rockefeller Neuroscience Institute, n=4; Weill Cornell Medical College, n=2), diagnosed by NIA-AA criteria and with 18F-florbetaben PET consistent with AD and amyloid-beta plaques in the target.
  • Main analysis: FUS was delivered with simultaneous IV microbubbles; safety was assessed with neurological exams and T2* MRI for hemorrhage, and BBB opening was evaluated by post-FUS gadobutrol contrast MRI with manual segmentation and comparison to targeted and overall hippocampal volumes.

## Limitations

  • The paper frames these as initial/early outcomes from an ongoing multicenter trial, so efficacy conclusions are not yet established.
  • The study includes only 6 participants and 17 treatments, which limits generalizability; this limitation is evident from the text.
  • The paper reports safety/feasibility and imaging-based BBB opening, but does not state clinical benefit on cognition or AD progression beyond “no clinically meaningful changes” in short-term assessments; this limitation is evident from the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.2002571117

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. Illustration of FUS process and targeting. (A) The INSIGHTEC ultrasound system consists of a helmet with 1,024 ultrasound transducers attached to the MRI table. (B) Ultrasound beams travel transcranially to the target. Low-intensity (220 kHz) ultrasound energy beams interact with i.v. administered microbubbles. Subsequent oscillation of the microbubbles and acoustic cavitation cause transient opening of tight junctions in capillaries and open the BBB. Snapshot of the therapy planning software illustrating for a single subject (C) axial slice image of three targets in the hippocampus represented by circles, and (D) the estimated targeting volumes (5 × 5 × 7 mm3) represented as rectangles on the sagittal slice.
Fig. 1. Illustration of FUS process and targeting. (A) The INSIGHTEC ultrasound system consists of a helmet with 1,024 ultrasound transducers attached to the MRI table. (B) Ultrasound beams travel transcranially to the target. Low-intensity (220 kHz) ultrasound energy beams interact with i.v. administered microbubbles. Subsequent oscillation of the microbubbles and acoustic cavitation cause transient opening of tight junctions in capillaries and open the BBB. Snapshot of the therapy planning software illustrating for a single subject (C) axial slice image of three targets in the hippocampus represented by circles, and (D) the estimated targeting volumes (5 × 5 × 7 mm3) represented as rectangles on the sagittal slice.CC BY · PubMed Central
Fig. 2. MRI evidence of BBB opening and closure in six subjects. Baseline, immediately post-FUS, and 24-h post-FUS contrast-enhanced T1 axial MRI shows parenchymal contrast enhancement at targeted sites (arrows), indicating BBB opening, and resolution at 24 h, following repeat contrast administration, indicative of BBB closure.
Fig. 2. MRI evidence of BBB opening and closure in six subjects. Baseline, immediately post-FUS, and 24-h post-FUS contrast-enhanced T1 axial MRI shows parenchymal contrast enhancement at targeted sites (arrows), indicating BBB opening, and resolution at 24 h, following repeat contrast administration, indicative of BBB closure.CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 2 Not checked · 23 Own results and interpretations

10 more claims

Create a free account to see all 31 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 9
  • Probably not a substantial claim. 9
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 16 references

Cited by

See all 365

Metadata

Authors
Rezai, A. R., Ranjan, M., D’Haese, P.-F., Haut, M. W., Carpenter, J., Najib, U., Mehta, R. I., Chazen, J. L., Zibly, Z., Yates, J. R., Hodder, S. L., & Kaplitt, M.
Affiliations
  • West Virginia University (US)
  • Weill Cornell Medicine (US)
  • Sheba Medical Center (IL)
Corresponding author
Rezai, Ali R.
Venue
Proceedings of the National Academy of Sciences
Published
2020-04-13
Volume
117
Issue
17
Pages
9180-9182
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W3015813913
Cited by
365
References
16
Citations by year
2026: 45 · 2025: 75 · 2024: 62 · 2023: 61 · 2022: 62 · 2021: 48 · 2020: 12
FWCI
14.36
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • West Virginia Clinical and Translational Science Institute
  • Weill Cornell Medical College
  • National Institute of General Medical Sciences (U54GM104942)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
Keywords
blood-brain barrier opening, focused ultrasound, Alzheimer's disease, hippocampus, entorhinal cortex, MR-guided ultrasound, parenchymal enhancement, early Alzheimer's disease, treatment safety and feasibility
MeSH terms
Ultrasonic Waves, Aged, Alzheimer Disease, Biological Transport, Blood-Brain Barrier, Brain, Female, Hippocampus, Humans, Male, Middle Aged, Ultrasonography, Ultrasonic Therapy, Drug Delivery Systems, Microbubbles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound. https://app.cochat.ai/papers/10.1073/pnas.2002571117
The paper
Rezai, A. R., Ranjan, M., D’Haese, P.-F., Haut, M. W., Carpenter, J., Najib, U., Mehta, R. I., Chazen, J. L., Zibly, Z., Yates, J. R., Hodder, S. L., & Kaplitt, M. (2020). Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2002571117

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.